Unknown OBSERVATIONAL NCT01026662

In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue (eMatrixCO2)

Sponsor: Syneron Medical

Interventions Ablation and skin resurfacing eMatrixCO2

Updated 11 times since 2017 Last updated: Nov 28, 2014 Started: Nov 30, 2009 Primary completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01026662, this observational or N/A phase trial focuses on Abdominoplasty and remains ongoing. Sponsored by Syneron Medical, it has been updated 11 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: PHASE2_PHASE3 → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2017 — Aug 2017 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Syneron Medical

Data source: Syneron Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States